Inflamalps is a biopharmaceutical company established in Valais, Switzerland.
Our mission is ‘’to discover and develop novel medicines to treat inflammation with a focus on chronic inflammatory diseases of the eye”.
Our team comprises experienced pharmaceutical industry and biotechnology company managers with significant track record in drug development, management and financing.
Our focus is on developing topical treatments for inflammation-mediated diseases in ophthalmology.